Desq Long
Sign in

Cluster

XENE-2026-09-30-711d08b618e8

SEC FORM 4CLUSTER · 2 INSIDERS
$1,681,140.00

Xenon Pharmaceuticals Inc. (XENE)

Purchase of 45,000 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

  • Kelly Thomas Patrick, Chief Financial OfficerPurchase of 15,000 shares at $37.316 per share.$559,740.00
  • MORTIMER IAN, PRESIDENT & CEOPurchase of 30,000 shares at $37.38 per share.$1,121,400.00

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410001 · filed 2026-10-01 · View filing →

Source: SEC Form 4 · 0001193125-26-409999 · filed 2026-10-01 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Xenon Pharmaceuticals Inc. (XENE)." Disclosed 2026-10-01. https://desqlong.com/cards/cluster-XENE-2026-09-30-711d08b618e8 (retrieved 2026-10-02).